다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
BMB reports, v.48 no.5, 2015년, pp.256 - 265
Kim, Changsung (Department of Bioscience and Biotechnology, Sejong University)
AI-Helper
Cardiovascular and neurodegenerative diseases are major health threats in many developed countries. Recently, target tissues derived from human embryonic stem (hES) cells and induced pluripotent stem cells (iPSCs), such as cardiomyocytes (CMs) or neurons, have been actively mobilized for drug screen...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
1 Rajamohan D Matsa E Kalra S et al Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays (2013) 35 281 298 10.1002/bies.201200053 22886688
2 Rubin LL Haston KM Stem cell biology and drug discovery. BMC Biol (2011) 9 42 10.1186/1741-7007-9-42 21649940
3 Seok J Warren HS Cuenca AG et al Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 110 3507 3512 10.1073/pnas.1222878110 23401516
4 Munos B Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov (2009) 8 959 968 10.1038/nrd2961 19949401
5 Park IH Arora N Huo H et al Disease-specific induced pluripotent stem cells. Cell (2008) 134 877 886 10.1016/j.cell.2008.07.041 18691744
6 Takahashi K Tanabe K Ohnuki M et al Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 131 861 872 10.1016/j.cell.2007.11.019 18035408
7 Takahashi K Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 126 663 676 10.1016/j.cell.2006.07.024 16904174
8 Ban H Nishishita N Fusaki N et al Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A (2011) 108 14234 14239 10.1073/pnas.1103509108 21821793
9 Kim C Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application. Blood Res (2014) 49 7 14 10.5045/br.2014.49.1.7 24724061
10 Mercola M Ruiz-Lozano P Schneider MD Cardiac muscle regeneration: lessons from development. Genes Dev (2011) 25 299 309 10.1101/gad.2018411 21325131
11 Nascone N Mercola M An inductive role for the endoderm in Xenopus cardiogenesis. Development (1995) 121 515 523 7768189
12 Kim C Majdi M Xia P et al Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev (2010) 19 783 795 10.1089/scd.2009.0349 20001453
13 Filipczyk AA Passier R Rochat A et al Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci (2007) 64 704 718 10.1007/s00018-007-6523-2 17380311
14 Yang L Soonpaa MH Adler ED et al Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 453 524 528 10.1038/nature06894 18432194
15 Lian X Hsiao C Wilson G et al Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A (2012) 109 E1848 1857 10.1073/pnas.1200250109 22645348
16 Moretti A Bellin M Welling A et al Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med (2010) 363 1397 1409 10.1056/NEJMoa0908679 20660394
17 Itzhaki I Maizels L Huber I et al Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 471 225 229 10.1038/nature09747 21240260
18 Yazawa M Hsueh B Jia X et al Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature (2011) 471 230 234 10.1038/nature09855 21307850
19 Ruan Y Liu N Napolitano C Priori SG Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol (2008) 1 290 297 10.1161/CIRCEP.108.795617 19808421
20 Terrenoire C Wang K Tung KW et al Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol (2013) 141 61 72 10.1085/jgp.201210899 23277474
21 Moreno JD Clancy CE Pathophysiology of the cardiac late Na current and its potential as a drug target. J Mol Cell Cardiol (2012) 52 608 619 10.1016/j.yjmcc.2011.12.003 22198344
22 Carvajal-Vergara X Sevilla A D'Souza SL et al Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 465 808 812 10.1038/nature09005 20535210
23 Lan F Lee AS Liang P et al Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell (2013) 12 101 113 10.1016/j.stem.2012.10.010 23290139
24 Tabar V Studer L Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet (2014) 15 82 92 10.1038/nrg3563 24434846
25 Zhang SC Wernig M Duncan ID Brüstle O Thomson JA In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol (2001) 19 1129 1133 10.1038/nbt1201-1129 11731781
26 Reubinoff BE Itsykson P Turetsky T et al Neural progenitors from human embryonic stem cells. Nat Biotechnol (2001) 19 1134 1140 10.1038/nbt1201-1134 11731782
27 Chambers SM Fasano CA Papapetrou EP Tomishima M Sadelain M Studer L Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 27 275 280 10.1038/nbt.1529 19252484
28 Kondo T Asai M Tsukita K et al Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell (2013) 12 487 496 10.1016/j.stem.2013.01.009 23434393
29 Yagi T Ito D Okada Y et al Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet (2011) 20 4530 4539 10.1093/hmg/ddr394 21900357
30 Wang H Doering LC Induced pluripotent stem cells to model and treat neurogenetic disorders. Neural Plast (2012) 2012 346053 22888453
31 Israel MA Yuan SH Bardy C et al Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature (2012) 482 216 220 22278060
32 Brennand KJ Simone A Jou J et al Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 473 221 225 10.1038/nature09915 21490598
33 Ryan SD Dolatabadi N Chan SF et al Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell (2013) 155 1351 1364 10.1016/j.cell.2013.11.009 24290359
34 Kaye JA Finkbeiner S Modeling Huntington's disease with induced pluripotent stem cells. Mol Cell Neurosci (2013) 56 50 64 10.1016/j.mcn.2013.02.005 23459227
35 Jeon I Lee N Li JY et al Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells (2012) 30 2054 2062 10.1002/stem.1135 22628015
36 Zhang K Yi F Liu GH Izpisua Belmonte JC Huntington's disease: dancing in a dish. Cell Res (2012) 22 1627 1630 10.1038/cr.2012.116 22868272
37 Williams EC Zhong X Mohamed A et al Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet (2014) 23 2968 2980 10.1093/hmg/ddu008 24419315
38 Jeon I Choi C Lee N et al In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. Int J Stem Cells (2014) 7 43 47 10.15283/ijsc.2014.7.1.43 24921027
39 Yang J Cai J Zhang Y et al Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem (2010) 285 40303 40311 10.1074/jbc.M110.183392 20956530
40 Dajani R Koo SE Sullivan GJ Park IH Investigation of Rett syndrome using pluripotent stem cells. J Cell Biochem (2013) 114 2446 2453 10.1002/jcb.24597 23744605
41 Ananiev G Williams EC Li H Chang Q Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One (2011) 6 e25255 10.1371/journal.pone.0025255 21966470
42 Schöndorf DC Aureli M McAllister FE et al iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun (2014) 5 4028 24905578
43 Chamberlain SJ Chen PF Ng KY et al Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A (2010) 107 17688 17673 10.1073/pnas.1004487107
44 Sareen D Ebert AD Heins BM McGivern JV Ornelas L Svendsen CN Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One (2012) 7 e39113 10.1371/journal.pone.0039113 22723941
45 Egawa N Inoue H [ALS disease modeling and drug screening using patient-specific iPS cells]. Rinsho Shinkeigaku (2013) 53 1020 1022 10.5692/clinicalneurol.53.1020 24291866
46 Corti S Nizzardo M Simone C et al Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med (2012) 4 165ra162 10.1126/scitranslmed.3004108
47 Ross CA Akimov SS Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet (2014) 23 R17 26 10.1093/hmg/ddu204 24824217
48 Kiskinis E Sandoe J Williams LA et al Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1. Cell Stem Cell (2014) 14 781 795 10.1016/j.stem.2014.03.004 24704492
49 Chen H Qian K Du Z et al Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons. Cell Stem Cell (2014) 14 796 809 10.1016/j.stem.2014.02.004 24704493
50 Wolstencroft EC Mattis V Bajer AA Young PJ Lorson CL A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum Mol Genet (2005) 14 1199 1210 10.1093/hmg/ddi131 15790598
51 Makhortova NR Hayhurst M Cerqueira A A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol (2011) 7 544 552 10.1038/nchembio.595 21685895
52 Guo X Disatnik MH Monbureau M Shamloo M Mochly-Rosen D Qi X Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 123 5371 5388 10.1172/JCI70911 24231356
53 Charbord J Poydenot P Bonnefond C et al High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells (2013) 31 1816 1828 10.1002/stem.1430 23712629
54 Miller JD Ganat YM Kishinevsky S et al Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 13 691 705 10.1016/j.stem.2013.11.006 24315443
55 Kim C Wong J Wen J et al Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature (2013) 494 105 110 10.1038/nature11799 23354045
56 Reinhardt P Schmid B Burbulla LF et al Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell (2013) 12 354 367 10.1016/j.stem.2013.01.008 23472874
57 Lopaschuk GD Jaswal JS Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol (2010) 56 130 140 10.1097/FJC.0b013e3181e74a14 20505524
58 Djouadi F Lecarpentier Y Hébert JL Charron P Bastin J Coirault C A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res (2009) 84 83 90 10.1093/cvr/cvp183 19497962
59 Eroshenko N Ramachandran R Yadavalli VK Rao RR Effect of substrate stiffness on early human embryonic stem cell differentiation. J Biol Eng (2013) 7 7 10.1186/1754-1611-7-7 23517522
60 Engler AJ Carag-Krieger C Johnson CP et al Embryonic cardiomyocytes beat best on a matrix with heartlike elasticity: scar-like rigidity inhibits beating. J Cell Sci (2008) 121 3794 3802 10.1242/jcs.029678 18957515
61 Galie PA Khalid N Carnahan KE Westfall MV Stegemann JP Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes. Cardiovasc Pathol (2013) 22 219 227 10.1016/j.carpath.2012.10.003 23266222
62 Choi SM Kim Y Shim JS et al Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells Hepatology (2013) 57 2458 2468 10.1002/hep.26237 23325555
63 Hidvegi T Ewing M Hale P et al An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science (2010) 329 229 232 10.1126/science.1190354 20522742
64 Höing S Rudhard Y Reinhardt P et al Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. Cell Stem Cell (2012) 11 620 632 10.1016/j.stem.2012.07.005 23064101
65 Yang YM Gupta SK Kim KJ et al A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell (2013) 12 713 726 10.1016/j.stem.2013.04.003 23602540
66 Fermini B Fossa AA The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov (2003) 2 439 447 10.1038/nrd1108 12776219
67 Zeevi-Levin N Itskovitz-Eldor J Binah O Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol Ther (2012) 134 180 188 10.1016/j.pharmthera.2012.01.005 22269465
68 De Bruin ML Pettersson M Meyboom RH Hoes AW Leufkens HG Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J (2005) 26 590 597 10.1093/eurheartj/ehi092 15637086
69 Liang P Lan F Lee AS et al Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation (2013) 127 1677 1691 10.1161/CIRCULATIONAHA.113.001883 23519760
70 Grant AO Cardiac ion channels. Circ Arrhythm Electrophysiol (2009) 2 185 194 10.1161/CIRCEP.108.789081 19808464
71 Knollmann BC Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res (2013) 112 969 976 discussion 976 10.1161/CIRCRESAHA.112.300567 23569106
72 Musunuru K Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech (2013) 6 896 904 10.1242/dmm.012054 23751357
73 Kim H Kim JS A guide to genome engineering with programmable nucleases. Nat Rev Genet (2014) 15 321 334 10.1038/nrg3686 24690881
74 Maeder ML Linder SJ Cascio VM Fu Y Ho QH Joung JK CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 10 977 979 10.1038/nmeth.2598 23892898
75 Qiang L Fujita R Abeliovich A Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. Neuron (2013) 78 957 969 10.1016/j.neuron.2013.06.002 23791192
76 Wada R Muraoka N Inagawa K et al Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A (2013) 110 12667 12672 10.1073/pnas.1304053110 23861494
77 Fu JD Stone NR Liu L et al Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State. Stem Cell Reports (2013) 1 235 247 10.1016/j.stemcr.2013.07.005 24319660
78 Cerrone M Lin X Zhang M et al Missense mutations in plakophilin-2 cause sodium current deficit and associate with a brugada syndrome phenotype. Circulation (2014) 129 1092 1103 10.1161/CIRCULATIONAHA.113.003077 24352520
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.